Source: Markets Insider

PNAS: PNAS Published Preclinical Results of Harbour BioMed's Next-Generation Fully Human Heavy-chain Antibody Porustobart

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 8, 2022 /PRNewswire/ -- Harbour BioMed (the 'Company', HKEX: 02142) announced tha...

Read full article »
PNAS's Competitors | PNAS's News | PNAS's Financials
Stay up-to-date with the latest news on PNAS
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Kenneth R. Fulton's photo - General Manager of PNAS

General Manager

Kenneth R. Fulton

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on PNAS